Who owns Ernexa Therapeutics Inc?
- Ticker: ERNA
- CUSIP Number: 114082308
Tip: Access positions for across all investors
Analyze quarterly positions in Ernexa Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ernexa Therapeutics stock
Who bought or sold Ernexa Therapeutics Inc this quarter?
There are no current stakeholders of Ernexa Therapeutics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Ernexa Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bleichroeder | Mar 2026 | 2.0M | $398k |
| Dauntless Investment Group | Mar 2026 | 612k | $122k |
| CI Private Wealth | Mar 2026 | 438k | $87k |
| Geode Capital Management | Mar 2026 | 244k | $49k |
| XTX Topco | Mar 2026 | 54k | $11k |
| Warberg Asset Management | Mar 2026 | 50k | $10k |
| Jane Street | Mar 2026 | 41k | $8.2k |
| Citadel Advisors | Mar 2026 | 33k | $6.6k |
| Vanguard Capital Management | Mar 2026 | 27k | $5.3k |
| Vanguard Fiduciary Trust | Mar 2026 | 25k | $5.1k |
| UBS Group | Mar 2026 | 21k | $4.2k |
| Goldman Sachs Group | Mar 2026 | 17k | $3.3k |
| Sippican Capital Adivsors | Mar 2026 | 10k | $2.0k |
| BlackRock | Mar 2026 | 820.00 | $163.016000 |
| Assetmark | Mar 2026 | 133.00 | $26.001500 |
| Morgan Stanley | Dec 2025 | 30.00 | $36.000000 |
| Bnp Paribas Arbitrage, Snc | Mar 2026 | 10.00 | $2.000000 |
| A. Montag and Associates | Mar 2026 | 8.00 | $2.000000 |
| SBI Securities | Mar 2026 | 6.00 | $1.000200 |